Wenbin Xu
No. 197 Rui Jin Er Road
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Targeting MTHFD2 alters metabolic homeostasis and synergizes with bortezomib to inhibit multiple myeloma.
Journal: Cell death discovery
Published: November 21, 2024
IRF4-BLOC1S5: the first rearrangement gene identified in TEMPI syndrome.
Journal: Haematologica
Published: November 25, 2023
Indisulam synergizes with melphalan to inhibit Multiple Myeloma malignancy via targeting TOP2A.
Journal: PloS one
Published: June 25, 2023
Regional differentiation based on volatile compounds via HS-SPME/GC-MS and chemical compositions comparison of hemp (Cannabis sativa L.) seeds.
Journal: Food research international (Ottawa, Ont.)
Published: June 22, 2022
Motion Similarity Evaluation between Human and a Tri-Co Robot during Real-Time Imitation with a Trajectory Dynamic Time Warping Model.
Journal: Sensors (Basel, Switzerland)
Published: January 04, 2022
JaponiconeA induces apoptosis of bortezomib-sensitive and -resistant myeloma cells in vitro and in vivo by targeting IKK.
Journal: Cancer biology & medicine
Published: September 27, 2021
Montelukast enhances cytocidal effects of carfilzomib in multiple myeloma by inhibiting mTOR pathway.
Journal: Cancer biology & therapy
Published: October 26, 2018
Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 28, 2017
Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance.
Journal: Leukemia & lymphoma
Published: July 22, 2016
Last Updated: 09/26/2026